A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Multiple Doses of ABT-333 Alone and in Combination With Pegylated Interferon (pegIFN) and Ribavirin (RBV) in Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel Cohen, MD
AbbVie
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site Reference Id/investigator# 16182
Santurce, Puerto Rico
- Site Reference Id/investigator# 16103
Anaheim, California, United States
- Site Reference Id/investigator# 16124
Los Angeles, California, United States
- Site Reference Id/investigator# 16102
Orlando, Florida, United States
- Site Reference Id/investigator# 16105
Baton Rouge, Louisiana, United States
- Site Reference Id/investigator# 16106
Chapel Hill, North Carolina, United States
- Site Reference Id/investigator# 16107
Dallas, Texas, United States
- Site Reference Id/investigator# 16123
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2009
- Primary completion
- 31 Jul 2009
- Completion
- 31 Jul 2009
- Last update posted
- 2 Jul 2018
- Registered enrollment
- 30
- Registry id
- NCT00851890
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.